Jon Congleton

Director; Director, Chief Executive Officer · 3 filings · Latest: Apr 29, 2026

Avalyn Pharma Inc.

Mineralys Therapeutics, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MLYS	Jon Congleton	Director, Chief Executive Officer	Apr 13, 2026	Sale	$26.83	15,730	$422.0K	689,321	Apr 15 9:45 PM
MLYS	Jon Congleton	Director, Chief Executive Officer	Mar 31, 2026	Sale	$26.27	75,000	$2.0M	705,051	Apr 2 6:54 PM